Preclinical development of a docetaxel nanocarrier to enhance prostate cancer radiosensitivity.

Gilles Crehange, Julien Boudon, Romain Boidot, Sandy Chevrier, Cecile Dalban, Alexis Loiseau, Bertrand Collin, Alexandra Oudot, Thomas Gauthier, Nadine Millot, Celine Mirjolet

Open source

DOI: 10.1200/jco.2015.33.7_suppl.41
Published: 2015-03-01
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.2015.33.7_suppl.41,
  title = {Preclinical development of a docetaxel nanocarrier to enhance prostate cancer radiosensitivity.},
  author = {Gilles Crehange and Julien Boudon and Romain Boidot and Sandy Chevrier and Cecile Dalban and Alexis Loiseau and Bertrand Collin and Alexandra Oudot and Thomas Gauthier and Nadine Millot and Celine Mirjolet},
  year = {2015},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco.2015.33.7_suppl.41},
  url = {https://doi.org/10.1200/jco.2015.33.7_suppl.41}
}

RIS

TY  - JOUR
TI  - Preclinical development of a docetaxel nanocarrier to enhance prostate cancer radiosensitivity.
AU  - Gilles Crehange
AU  - Julien Boudon
AU  - Romain Boidot
AU  - Sandy Chevrier
AU  - Cecile Dalban
AU  - Alexis Loiseau
AU  - Bertrand Collin
AU  - Alexandra Oudot
AU  - Thomas Gauthier
AU  - Nadine Millot
AU  - Celine Mirjolet
PY  - 2015
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco.2015.33.7_suppl.41
UR  - https://doi.org/10.1200/jco.2015.33.7_suppl.41
ER  -

APA

Crehange, G., Boudon, J., Boidot, R., Chevrier, S., Dalban, C., Loiseau, A., Collin, B., Oudot, A., Gauthier, T., Millot, N., & Mirjolet, C. (2015). Preclinical development of a docetaxel nanocarrier to enhance prostate cancer radiosensitivity.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2015.33.7_suppl.41

Source records

crossref · retrieved 2026-09-26T15:14:58.853Z